Wellspring Ophthalmics, Inc. is a development stage eye care pharmaceutical company focused on innovating an improved, effective dry eye therapy by unlocking the power of cyclosporine for superior dry eye relief. The Company owns the patent portfolio for a novel dry eye therapy comprising a broad formulation platform for a unique suspension containing aqueous, amorphous nanodispersions of cyclosporine. Wellspring Ophthalmics a...
Wellspring Ophthalmics, Inc. is a development stage eye care pharmaceutical company focused on innovating an improved, effective dry eye therapy by unlocking the power of cyclosporine for superior dry eye relief. The Company owns the patent portfolio for a novel dry eye therapy comprising a broad formulation platform for a unique suspension containing aqueous, amorphous nanodispersions of cyclosporine. Wellspring Ophthalmics aims to license its intellectual property portfolio, including issued and pending patents, to a licensee who will complete development of and commercialize its innovation.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.